MoneyWorks4Me

RPG Life Sciences informs about investor presentation

28 Jan 2026 Evaluate
In furtherance to letter dated January 27, 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, RPG Life Sciences has enclosed a revised Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter ended December 31, 2025.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..